Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Us...

Cijeli opis

Bibliografski detalji

Glavni autori:	Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo
Format:	Artigo
Jezik:	Inglês
Izdano:	Oxford University Press 2025-10-01
Serija:	ESC Heart Failure
Teme:	Heart failure, systolic Hospitalization Kidney failure, chronic Mortality Renin‐angiotensin system Treatment outcome
Online pristup:	https://doi.org/10.1002/ehf2.15359
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!